![]() Deciphera Pharmaceuticals Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer. | ![]() NiKang Therapeutics NiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines. | ||
Founding Date | Founding Date 1994 | Founding Date 2003 | Founding Date 2017 |
Type | Type Public | Type Public | Type Private |
Tags | |||
Locations | Locations Alameda, US HQ | Locations Waltham, US HQ Lawrence, US | Locations Wilmington, US HQ |
Employees | Employees 1,3107% increase | Employees 35037% increase | Employees 417% decrease |
Valuation ($) | Valuation ($) 8.2 b | Valuation ($) 2.2 b | Valuation ($) N/A |
Financial | |||
Revenue (est.) | Revenue (est.) $1.8b (FY, 2023) | Revenue (est.) $163.4m (FY, 2023) | Revenue (est.) N/A |
Cost of goods | Cost of goods $72.5m (FY, 2023) | Cost of goods $3.7m (FY, 2023) | Cost of goods N/A |
Gross profit | Gross profit $1.8b (FY, 2023) | Gross profit $159.6m (FY, 2023) | Gross profit N/A |
Net income | Net income $207.8m (FY, 2023) | Net income ($194.9m) (FY, 2023) | Net income N/A |
Funding | |||
Total funding raised | Total funding raised N/A | Total funding raised $ 714m | Total funding raised $ 200m |
Deciphera Pharmaceuticals is a clinical-stage biopharmaceutical company that develops medicines for patients with cancer.
View companyNiKang Therapeutics is a biotech company focused on developing small molecule oncology medicines.
View company